e-Newsletter – February 2023
Our monthly e-Newsletter featuring the latest updates from Retina UK. Subscribe now to receive these updates directly to your email.
Search
Search results
Lake District Eight Peaks Challenge 2025
Take on one of the Lake District's toughest challenges and be rewarded with epic panoramic views from the highest peaks in England, in aid of Retina UK.
Volunteering FAQs
These are some of the most commonly asked questions about volunteering for our charity.
Gene therapy shows promise in tackling X-linked RP
Early results from clinical testing of a gene therapy to treat X-linked retinitis pigmentosa (XLRP) have shown partial reversal of sight loss in some patients.
Discover Wellbeing
We have created Discover Wellbeing to help people affected by inherited sight loss to develop an awareness of emotional wellbeing and the practical skills to adapt to life’s ups and downs.
Nanoscope Announces topline results from randomised phase 2B trial of MCO-010 for retinitis pigmentosa
Nanoscope Therapeutics has announced positive results from their two year randomised controlled phase 2b optogenetic therapy trial for late-stage retinitis pigmentosa (RP).
Retina UK Clinical and Patient Registry Focus Groups
Retina UK Clinical and Patient Registry Focus Groups
Research update – ProQR
In February 2022, ProQR announced a disappointing outcome for their phase 2/3 trial of sepofarsen for Leber congenital amaurosis type 10 (LCA10).
Bright Futures: Empowering young adults with inherited sight loss
Join us for an inspiring webinar where young adults living with sight loss share their extraordinary stories and insights.
Meet our Trustee: Dr Elizabeth Graham FRCP FRCOphth
Dr Graham undertook research into the basic mechanisms of retinal vasculitis, inflammation of the blood vessels in the retina, and is an important cause of poor vision in patients with uveitis, inflammation of the uveal tract.